Evidence map›Paper›PMID 29326438›Full record

ArticleOncogene2018

Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumors.

Hawley C Pruitt, Brandon J Metge, Shannon E Weeks, Dongquan Chen, Shi Wei, Robert A Kesterson, Lalita A Shevde, Rajeev S Samant

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Functions of Tomato (International journal of molecular sciences · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hawley C PruittDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Brandon J MetgeDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Shannon E WeeksDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Dongquan ChenDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Shi WeiDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Robert A KestersonDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
Lalita A ShevdeDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Rajeev S SamantDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA. rsamant@uab.edu.ORCID http://orcid.org/0000-0001-5681-4976
University of Alabama at Birmingham · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
Training Program in Cell, Molecular, and Developmental BiologyT32GM008111 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YODER, BRADLEY K. · 1985 to 2022
$5.4M
Dietary intervention of non-classical Wnt signalingR01CA194048 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAMANT, RAJEEV S · 2016 to 2020
$1.7M
Mechanisms of resistance to cancer therapeuticsR01CA169202 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SHEVDE, LALITA A. · 2014 to 2018
$1.5M
Role of Nmi in retarding breast tumor growth.R01CA140472 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI SAMANT, RAJEEV S · 2010 to 2014
$1.3M
Mechanisms that impact metastatic progression of triple negative breast cancerI01BX003374 · VA · BIRMINGHAM VA MEDICAL CENTER · PI SAMANT, RAJEEV S · 2017 to 2024
–
BLRD VA I01 BX003374NCATS NIH HHS UL1 TR001417NCI NIH HHS P30 CA013148NCI NIH HHS R01 CA140472NCI NIH HHS R01 CA169202NCI NIH HHS R01 CA194048NIGMS NIH HHS T32 GM008111
6 · The paper itself

Abstract

The process of organ development requires a delicate balance between cellular plasticity and differentiation. This balance is disrupted in cancer initiation and progression. N-Myc and STAT interactor (NMI: human or Nmi: murine) has emerged as a relevant player in the etiology of breast cancer. However, a fundamental understanding of its relevance to normal mammary biology is lacking. To gain insight into its normal function in mammary gland, we generated a mammary-specific Nmi knockout mouse model. We observed that Nmi protein expression is induced in mammary epithelium at the onset of pregnancy, in luminal cells and persists throughout lactation. Nmi knockout results in a precocious alveolar phenotype. These alveoli exhibit an extensive presence of nuclear β-catenin and enhanced Wnt/β-catenin signaling. The Nmi knockout pubertal ductal tree shows enhanced invasion of the mammary fatpad and increased terminal end bud numbers. Tumors from Nmi null mammary epithelium show a significant enrichment of poorly differentiated cells with elevated stem/progenitor markers, active Wnt/β-catenin signaling, highly invasive morphology as well as, increased number of distant metastases. Our study demonstrates that Nmi has a distinct role in the differentiation process of mammary luminal epithelial cell compartment and developmental aberrations resulting from Nmi absence contribute to metastasis and demonstrates that aberration in normal developmental program can lead to metastatic disease, highlighting the contribution and importance of luminal progenitor cells in driving metastatic disease.

Indexed as

AnimalsBreastBreast NeoplasmsCell DifferentiationCells, CulturedFemaleHumansIntracellular Signaling Peptides and ProteinsMammary Glands, AnimalMammary Glands, HumanMammary Neoplasms, AnimalMiceMice, Inbred C57BLMice, KnockoutNeoplasm MetastasisOrganogenesisIntracellular Signaling Peptides and ProteinsNMI protein, humanNMI protein, mouse

Identifiers

PMID29326438
PMCPMC5921859
OpenAlexW2783147806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.